BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 16439055)

  • 1. HIFU ablation is not a proven standard treatment for localized prostate cancer.
    So AI
    Can Urol Assoc J; 2011 Dec; 5(6):424-6. PubMed ID: 22154640
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of imaging and biopsy to assess local recurrence after definitive treatment for prostate carcinoma (surgery, radiotherapy, cryotherapy, HIFU).
    Martino P; Scattoni V; Galosi AB; Consonni P; Trombetta C; Palazzo S; Maccagnano C; Liguori G; Valentino M; Battaglia M; Barozzi L
    World J Urol; 2011 Oct; 29(5):595-605. PubMed ID: 21553276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion weighted imaging in prostate cancer.
    Tan CH; Wang J; Kundra V
    Eur Radiol; 2011 Mar; 21(3):593-603. PubMed ID: 20936413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of prostate cancer local recurrences: why and how?
    Rouvière O; Vitry T; Lyonnet D
    Eur Radiol; 2010 May; 20(5):1254-66. PubMed ID: 19921202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer transrectal HIFU ablation: detection of local recurrences using T2-weighted and dynamic contrast-enhanced MRI.
    Rouvière O; Girouin N; Glas L; Ben Cheikh A; Gelet A; Mège-Lechevallier F; Rabilloud M; Chapelon JY; Lyonnet D
    Eur Radiol; 2010 Jan; 20(1):48-55. PubMed ID: 19690866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transrectal high-intensity focused ultrasound ablation of prostate cancer: effective treatment requiring accurate imaging.
    Rouvière O; Souchon R; Salomir R; Gelet A; Chapelon JY; Lyonnet D
    Eur J Radiol; 2007 Sep; 63(3):317-27. PubMed ID: 17689218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
    Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
    BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Location of residual cancer after transrectal high-intensity focused ultrasound ablation for clinically localized prostate cancer.
    Boutier R; Girouin N; Cheikh AB; Belot A; Rabilloud M; Gelet A; Chapelon JY; Rouvière O
    BJU Int; 2011 Dec; 108(11):1776-81. PubMed ID: 21711432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Intensity Focused Ultrasound (HIFU): a useful alternative choice in prostate cancer treatment. Preliminary results.
    Maestroni U; Ziveri M; Azzolini N; Dinale F; Ziglioli F; Campaniello G; Frattini A; Ferretti S
    Acta Biomed; 2008 Dec; 79(3):211-6. PubMed ID: 19260381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.
    Murat FJ; Poissonnier L; Rabilloud M; Belot A; Bouvier R; Rouviere O; Chapelon JY; Gelet A
    Eur Urol; 2009 Mar; 55(3):640-7. PubMed ID: 18508188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure.
    Blana A; Brown SC; Chaussy C; Conti GN; Eastham JA; Ganzer R; Murat FJ; Pasticier G; Rebillard X; Rewcastle JC; Robertson CN; Thuroff S; Ward JF
    BJU Int; 2009 Oct; 104(8):1058-62. PubMed ID: 19388986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of color Doppler in guiding prostate biopsy after HIFU ablation.
    Rouvière O; Mège-Lechevallier F; Chapelon JY; Gelet A; Bouvier R; Boutitie F; Lyonnet D
    Eur Urol; 2006 Sep; 50(3):490-7. PubMed ID: 16439055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Principles and results of high-intensity focused ultrasound for localized prostate cancer.
    Colombel M; Gelet A
    Prostate Cancer Prostatic Dis; 2004; 7(4):289-94. PubMed ID: 15452554
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.